Ce que les psychiatres devraient savoir sur les effets indésirables cutanés des psychotropes.PIERARD, Gérald ; PITCHOT, William ![]() in Acta Psychiatrica Belgica (2011), 11 Detailed reference viewed: 9 (1 ULg) Le coma psychogèneDEBABECHE, Cécile ; PIETTE, Catherine ; Ansseau, Marc et alin Acta Psychiatrica Belgica (2011), 111(3), 20-25 Detailed reference viewed: 56 (2 ULg) Le cas clinique du mois. Syndrome sérotoninergique induit par une association isoniazide/venlafaxinePITCHOT, William ; Scantamburlo, Gabrielle ; Ansseau, Marc ![]() in Revue Médicale de Liège (2011), 66(12), 611-613 Detailed reference viewed: 17 (0 ULg) La dépression résistante : Définition et diagnosticPITCHOT, William ; ; Ansseau, Marc ![]() in Acta Psychiatrica Belgica (2011), 111(4), 13-19 Detailed reference viewed: 35 (3 ULg) Les antidépresseurs du futur : rôle du système glutamatergique.PITCHOT, William ; Scantamburlo, Gabrielle ; Ansseau, Marc ![]() in Revue Médicale de Liège (2011), 66(4), 195-198 Detailed reference viewed: 16 (0 ULg) Effets secondaires sexuels des antidépresseurs; ANSSEAU, Marc ; PITCHOT, William ![]() in Revue Médicale de Liège (2011) Detailed reference viewed: 69 (7 ULg) Les antidépresseurs tricycliques et les IMAO ont-ils encore une place dans le traitement de la dépression?PITCHOT, William ; SCANTAMBURLO, Gabrielle ; ANSSEAU, Marc ![]() in Revue Médicale de Liège (2011) Detailed reference viewed: 54 (4 ULg) Guérir la dépression : une question d'objectif et de détermination.PITCHOT, William ; Scantamburlo, Gabrielle ; Pinto, Emmanuel et alin Revue Médicale de Liège (2010), 65(5-6), 370-380 Detailed reference viewed: 15 (5 ULg) Delirium et anorexie; PIETTE, Catherine ; MAVROPOULOS, Gloria et alin Acta Psychiatrica Belgica (2010), 110 Detailed reference viewed: 50 (8 ULg) Duloxetine in major depressed patients resistant to SSRI and/or venlafaxinePITCHOT, William ; SCANTAMBURLO, Gabrielle ; ANSSEAU, Marc ![]() in Psychiatria Danubina (2010) Detailed reference viewed: 23 (2 ULg) Aripiprazole, hypertension, and confusion.Pitchot, William ; Ansseau, Marc ![]() in Journal of Neuropsychiatry and Clinical Neurosciences (The) (2010), 22(1), 12333 Detailed reference viewed: 19 (3 ULg) L'hypnose dans la prise en charge des douleurs chroniques; Faymonville, Marie-Elisabeth ; Pitchot, William et alin Acta Psychiatrica Belgica (2009), 109(3), 21-28 OUR REVIEW OF THE LITERATURE SUGGESTSTHAT HYPNOSIS IS AN USEFUL OPTION lN THE MANAGEMENT OF CHRONIC PAIN.THE EXPLANATIONS FOR ITS EFFECTIVENESS RELIE MAINLY ON THE FINDINGS OF FUNCTIONAL NEUROIMAGING ... [more ▼] OUR REVIEW OF THE LITERATURE SUGGESTSTHAT HYPNOSIS IS AN USEFUL OPTION lN THE MANAGEMENT OF CHRONIC PAIN.THE EXPLANATIONS FOR ITS EFFECTIVENESS RELIE MAINLY ON THE FINDINGS OF FUNCTIONAL NEUROIMAGING, CLINICAL STUDIES AND EMPIRICAL OBSERVATIONS. THESE DATA SHOWTHAT THROUGH THE DIVERSITY OF ITS EFFECTS, HYPNOSIS CAN MODULATE THE BIO-PSYCHO-SOCIAL DIMENSIONS OF CHRONIC PAIN. THE CHOICE OF THIS THERAPEUTIC TECHNIQUE SHOULD BE GUIDED BY THE ESTIMATE OF ITS USEFULNESS. THE EFFICACY IS ASSESSED ON AN INDIVIDUAL BASIS, TAKING INTO ACCOUNT THE BENEFITS AND LIMITATIONS OF HYPNOSIS FOR EACH PATIENT. [less ▲] Detailed reference viewed: 205 (36 ULg) Dependance au zolpidem et crise d'epilepsie.Pitchot, William ; Ansseau, Marc ![]() in Revue Médicale de Liège (2009), 64(7-8), 407-8 Zolpidem is an imidazopiridine with hypnotic properties. Compared to benzodiazepines, zolpidem has a mechanism of action that is thought to reduce the risk of dependence or abuse. However, in the past 10 ... [more ▼] Zolpidem is an imidazopiridine with hypnotic properties. Compared to benzodiazepines, zolpidem has a mechanism of action that is thought to reduce the risk of dependence or abuse. However, in the past 10 years, several cases of zolpidem abuse, dependence and withdrawal reactions have been described in the litterature. Here, we describe a case of dependence and withdrawal seizure. [less ▲] Detailed reference viewed: 73 (5 ULg) The TaqI A DRD2 polymorphism in type II alcohol dependence: a marker of age at onset or of a familial disease?Pinto, Emmanuel ; Reggers, Jean ; et alin Alcohol (2009), 43(4), 271-5 Cloninger's type II is a severe, early-onset, male-limited, and genetically influenced, impulsive form of alcoholism. Significant association has been reported between the A1 allele of the D2 dopamine ... [more ▼] Cloninger's type II is a severe, early-onset, male-limited, and genetically influenced, impulsive form of alcoholism. Significant association has been reported between the A1 allele of the D2 dopamine receptor (DRD2) gene, substance misuse and personality traits of impulsivity and novelty seeking. We assessed the association between the TaqI A DRD2 gene polymorphism with Cloninger's typology and family history of alcohol abuse, which is thought to be more frequent in type II alcoholics. Fifty-one male alcohol-dependent patients were discriminated between type I and type II according to age at onset of alcohol-related problems and interviewed about family history of alcoholism. The associations between DRD2 (A1 or A2 alleles), family history, and typology were assessed by Pearson's chi-square test. Although typology was not associated with the studied polymorphism, a higher rate of general family history of alcohol abuse was still observed in type II patients (chi(2)(1)=4.53; P=.033). Furthermore, the A1 allele of the DRD2 was significantly associated with paternal history of alcoholism (chi(2)(1)=4.66; P=.031) and male, first-degree, collateral history of alcoholism (chi(2)(1)=4.40; P=.036). Age at onset of alcohol-related problems as main discriminator between type I and type II alcohol dependence does not seem to be associated by the TaqI A DRD2 polymorphism. However, the A1 allele of the DRD2 may be a marker of male familial alcoholism, which has been associated with type II alcohol dependence. [less ▲] Detailed reference viewed: 39 (3 ULg) Dépression et neuroplasticité.Pitchot, William ; Polis, Marie-Hélène ; Belachew, Shibeshih et alin Revue Médicale de Liège (2008), 63 Detailed reference viewed: 49 (7 ULg) Shock-like sensations associated with duloxetine discontinuation.Pitchot, William ; Ansseau, Marc ![]() in Annals of Clinical psychiatry : Official Journal of the American Academy of Clinical Psychiatrists (2008), 20(3), 175 Detailed reference viewed: 81 (2 ULg) Therapeutic potential of repetitive transcranial magnetic stimulation in brainFumal, Arnaud ; Schoenen, Jean ; Maertens De Noordhout, Alain et alin Revue Médicale de Liège (2008), 63(5-6), 330-337 Detailed reference viewed: 26 (2 ULg) The short allele of the serotonin transporter promoter polymorphism influences relapse in alcohol dependence.Pinto, Emmanuel ; Reggers, Jean ; et alin Alcohol & Alcoholism (2008), 43 Detailed reference viewed: 21 (5 ULg) Vasopressin-neurophysin and DST in major depression : Relationship with suicidal behavior.Pitchot, William ; Scantamburlo, Gabrielle ; Pinto, Emmanuel et alin Journal of Psychiatric Research (2008), 42 The purpose of the present study was to assess if AVP-neurophysin is associated with hypercortisolemia and suicidal behaviour in depressed patients. The study included 28 patients subgrouped into suicide ... [more ▼] The purpose of the present study was to assess if AVP-neurophysin is associated with hypercortisolemia and suicidal behaviour in depressed patients. The study included 28 patients subgrouped into suicide attempters (n=13) and nonattempters (n=15). We assessed basal AVP-neurophysins concentrations and post-dexamethasone (DST) cortisol levels. Concentrations of AVP-neurophysins did not differ between DST suppressors and nonsuppressors: 0.29+/-0.13ng/ml vs 0.36+/-0.21ng/ml, (F=1.1, df=1, 27, p=0.30). Suicide attempters did not differ from nonattempters for AVP-neurophysins levels. Our results fail to support a role of AVP in the early cortisol escape. [less ▲] Detailed reference viewed: 101 (39 ULg) Les psychostimulants.Pinto, Emmanuel ; Pitchot, William ; Ansseau, Marc ![]() in Revue Médicale de Liège (2008), 63 Detailed reference viewed: 10 (0 ULg) |
||